Peer review reports
From: Optimal, minimax and admissible two-stage design for phase II oncology clinical trials
Original Submission | ||
---|---|---|
31 Jan 2019 | Submitted | Original manuscript |
3 Jun 2019 | Reviewed | Reviewer Report - Qing Li |
17 Feb 2020 | Reviewed | Reviewer Report - Adrian P. Mander |
20 Apr 2020 | Author responded | Author comments - Fei Qin |
13 May 2020 | Reviewed | Reviewer Report - Qing Li |
Resubmission - Version 2 | ||
20 Apr 2020 | Submitted | Manuscript version 2 |
Publishing | ||
15 May 2020 | Editorially accepted | |
20 May 2020 | Article published | 10.1186/s12874-020-01017-8 |